300841: Chengdu Kanghua Biological Products Co., Ltd. - Summary | Jitta

Chengdu Kanghua Biological Products Co., Ltd.

CHN:300841

Price
CN¥49.10
Loss Chance
50.9%
3.57JITTA SCORE
289.78%Over Jitta Line
Jitta Ranking
171 / 486
1,733 / 5,269
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (20)
Recent Business Performance (6)
Financial Strength (78)
Return to Shareholders (39)
Competitive Advantage (31)
Jitta Signs
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Interest Coverage RatioVery Good
Revenue and EarningRevenue decline from 2022-2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 51.78% in the last year
SG&A to SalesIncreasing
Cash Conversion CycleMore than 1 year
Key Stats
Jitta Score
Jitta Line
3.57
289.78%
3.55
873.71%
4.23
> 1,000%
Biotechnology
5.62
170.32%
7.60
2.00%
5.79
394.08%
COMPANY DESCRIPTION
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, and operation of biological products in China. It offers freeze-dried human rabies vaccines; ACYW135 meningococcal polysaccharide vaccine. The company was founded in 2004 and is based in Chengdu, China.